Genotyping Market Report 2026

Genotyping Market Overview

• Genotyping market size has reached to $26.55 billion in 2025 • Expected to grow to $60.54 billion in 2030 at a compound annual growth rate (CAGR) of 18% • Growth Driver: Increasing Genetic Testing Fuels The Genotyping Market Growth • Market Trend: Revolutionizing Genetic Analysis With Whole Genome Sequencing Solution In The Genotyping Market • North America was the largest region in 2025.

What Is Covered Under Genotyping Market?

Genotyping is a lab procedure examining a person’s germline DNA for nucleotides or bases to see if certain variations are present. Researchers can explore genetic variants such as single nucleotide variations, copy number variations, and substantial structural alterations in DNA using genotyping. It is used in various fields, including agriculture, medicine, and basic science. The main types of genotyping products and services are instruments, reagents and kits, bioinformatics, and genotyping services. An instrument refers to a tool used to measure something like speed, height, or sound. Instruments in genotyping are used to investigate genetic variations such as significant structural alterations in DNA, copy number variations, and single nucleotide variations. The multiple types of technology are included, such as microarrays, capillary electrophoresis, sequencing, polymerase chain reaction, matrix-assisted laser desorption or ionization (maldi-tof) mass spectrometry, and other technologies, which are used in several applications, including pharmacogenomics, diagnostics and personalized medicine, animal genetics, agricultural biotechnology, and others. These are used by several end-users, such as pharmaceutical and biopharmaceutical companies, diagnostics and research laboratories, academic institutes, and others.

What Is The Genotyping Market Growth Forecast?

The genotyping market size is expected to see rapid growth in the next few years. It will grow to $60.54 billion in 2030 at a compound annual growth rate (CAGR) of 18.0%. The growth in the forecast period can be attributed to expansion of precision medicine, growth in crop genetics research, declining genotyping costs, increased biopharma investment, integration with clinical diagnostics. Major trends in the forecast period include growing use of genotyping in personalized medicine, expansion of genotyping in agricultural biotechnology, rising adoption of high-throughput genotyping platforms, increased demand for pharmacogenomics applications, integration of bioinformatics in genotyping workflows.

Global Genotyping Market Segmentation

1) By Product And Services: Instruments, Reagents And Kits, Bioinformatics, Genotyping Service 2) By Technology: Microarrays, Capillary Electrophoresis, Sequencing, Polymerase Chain Reaction, Matrix-Assisted Laser Desorption Or Ionization (Maldi-Tof) Mass Spectrometry, Other Technologies 3) By Application: Pharmacogenomics, Diagnostics And Personalized Medicine, Animal Genetics, Agricultural Biotechnology, Other Applications 4) By End-User: Pharmaceutical And Biopharmaceutical Companies, Diagnostics And Research Laboratories, Academic Institutes, Other End-Users Subsegments: 1) By Instruments: Sequencers, PCR Machines, Microarrays, Genotyping Platforms 2) By Reagents And Kits: DNA Extraction Kits, PCR Reagents, SNP Genotyping Kits, Next-Generation Sequencing (NGS) Kits 3) By Bioinformatics: Data Analysis Software, Genomic Data Management Tools, Cloud-based Solutions 4) By Genotyping Services: Contract Research Organizations (CRO) Services, Custom Genotyping Services, Sample Preparation Services

What Is The Driver Of The Genotyping Market?

Rising demand for genetic testing is expected to propel the growth of the genotyping market going forward. Genetic testing, also known as DNA testing or molecular testing, involves the analysis of an individual’s DNA (deoxyribonucleic acid) to identify variations, mutations, or alterations in their genetic code. Genotyping is used in genetic testing to provide specific information about an individual’s genetic variations or differences in their DNA. For instance, in February 2025, according to the NHS England, a UK-based government healthcare agency, the NHS Genomic Medicine Service delivered over 810,000 genomic tests for patients across the life course in England in 2024. This has continued to increase year-on-year since the NHS Genomic Medicine Service was established and increased by 8% compared to 2023. Therefore, the rising demand for genetic testing is driving the growth of the genotyping industry.

Key Players In The Global Genotyping Market

Major companies operating in the genotyping market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Laboratory Corporation of America Holdings, Eurofins Scientific SE, Agilent Technologies, PerkinElmer Inc., Illumina Inc., Bio-Rad Laboratories Inc., QIAGEN NV, BGI Genomics, LGC Biosearch Technologies, GenScript Biotech, Inotiv, Takara Bio Inc., Integrated DNA Technologies Ltd., 23andMe Inc., Novogene Corporation, Oxford Nanopore Technologies, Macrogen Inc., Pacific Biosciences of California, Standard BioTools Inc., GENEWIZ, Transnetyx, Agena Bioscience Inc., Genotypic Technology Pvt Ltd., BMG LABTECH GmbH, Bioline, Biofortuna Limited, Xcelris Genomics

Global Genotyping Market Trends and Insights

Major companies operating in the genotyping market are concentrating their efforts on developing innovative solutions such as high-coverage whole genome sequencing. High-coverage whole genome sequencing (WGS) is a comprehensive and advanced genetic sequencing technique that involves analyzing an individual's entire genome with a high degree of coverage. For instance, in September 2023, CD Genomics, a U.S.-based provider of genomics, transcriptomics, and bioinformatics services, launched its Genotyping by Sequencing (GBS) service, which uses next generation sequencing combined with restriction enzyme digestion to deliver high-throughput, cost effective genome wide SNP genotyping for large sample sets. CD Genomics’ Genotyping by Sequencing (GBS) launch offers high-throughput, cost-efficient variant detection with streamlined library preparation to accelerate genomic discovery. The platform provides dense genome-wide marker coverage and scalable multiplexing, enabling rapid, accurate genotyping across diverse species.

What Are Latest Mergers And Acquisitions In The Genotyping Market?

In February 2023, NIMGenetics, a Spain-based provider of clinical genetic diagnostic services including genome sequencing, exome sequencing, and precision medicine testing, acquired Gene Predictis for an undisclosed amount. With this acquisition, NIMGenetics aims to expand its presence in Central Europe and strengthen its genomics-diagnostic offering through advanced preventive genetics and pharmacogenomics capabilities. Gene Predictis is a Switzerland-based provider of precision medicine services, specializing in polygenic risk scores, pharmacogenomics tests, and preventive-genetics solutions based on genotyping and genetic data interpretation.

Regional Outlook

North America was the largest region in genotyping market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Genotyping Market?

The genotyping market consists of revenues earned by entities by providing services such as custom genotyping services, genetic counselling, genotyping assay services, Sanger sequencing, fragment length analysis, and genotyping data analysis. The market value includes the value of related goods sold by the service provider or included within the service offering. The genotyping market also includes sales of thermal cyclers, PCR (polymerase chain reaction) systems, fully integrated microarray instrument, which are used in providing genotyping services. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Genotyping Market Report 2026?

The genotyping market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the genotyping industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.